Biopharmaceuticals
HIV/AIDS
News Release - January 31, 2007
Polydex Pharmaceuticals Reports Phase III Trial of Ushercell for HIV Prevention Halted
Source: Polydex Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.